$2.69
Currently 8 wall-street analysts regularly analyze the financials of Immunitybio Inc. on a frequent basis to provide recommendations along with target share price. 8 analysts offering 12-month price forecasts for Immunitybio Inc. (IBRX) have a share price target of $13. This median of share price forecast represents a 383.27% upside from the latest price of $2.69 as on 25.04.25.
As per the chart shown above, analysts believe that the Immunitybio Inc. (IBRX) share price will touch around $13 in next 12-months.
Below is a chart showing the percentage difference between Immunitybio Inc.'s share price and its median forecast price. As on 25.04.25, the difference is -77.23%
Based on 8 analysts tracking and researching Immunitybio Inc. (IBRX) share have buy recommendation on an average.
3M Ago | 1M Ago | Current | |
Buy | 0 | 0 | 3 |
Outperform | 0 | 0 | 3 |
Hold | 3 | 3 | 2 |
Underperform | 2 | 2 | 0 |
Sell | 1 | 1 | 0 |